How to Get Started in Social Media for Art League City
The MPS at GSK
1. Insights into the Supply Planning
Process
Courtney Clark, Jan Szydlowski, Sergio Rivera
Claudia De Bourg, Daniel Schwartz, Rex Agbajor
Supply & Demand
Group #2
The MPS at
GlaxoSmithKli
ne
4. Company Overview
GSK Targets
Respiratory Illnesses
Diabetes
Viral Control
Infections
Central Nervous System Disorders
Scale of GSK
99 000+ employed
Operating in 115 countries
CAD $47 billion annual revenue in 2013
4
5. Operations
GSK Mississauga Facility
Sells exclusively to internal GSK customers
Produces liquids, tablets and ointments
Components of Finished Goods
Active Pharmaceutical Ingredients (API) -
substances that are responsible for the beneficial
health effects
Excipients – preservatives / stability materials
Primary and Secondary Components - packaging
5
6. Supply Planning Process -
Demand
Forecasts for:
USA (Mainly)
Latin America
Parts of Asia
(I.e. Japan)
Parts of
Europe
Canada
(<10%)
Family Level
(J. Shang et al. 2008)
6
7. Supply Planning Process –
S&OP
Vital
component of
the process
Integrates all
departments
Shapes
demand inputs
for MPS
7
(J. Shang et al. 2008)
8. Supply Planning Process –
Inventory
Raw Materials
Highly perishable
Expensive
Major Risk
Finished Good
Not inventoried
Longer shelf life
Distributor carries
risk
Must be monitored
very closely
through ERP
8
(J. Shang et al. 2008)